TherapeuticsMD, Inc. — Director's Dealing 2022

Jul 19, 2022

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: TherapeuticsMD, Inc. (TXMD)
CIK: 0000025743
Period of Report: 2022-07-14

Reporting Person: Rubric Capital Management LP (10% Owner)
Reporting Person: Rosen David Efraim (10% Owner)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common stock, par value $0.001 per share	1074373	Indirect

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Total Return Swap	$0	2025-01-13	Common stock, par value $0.001 per share (128254)		Indirect

Footnotes

F1: This Form 3 is filed by Rubric Capital Management LP ("Rubric Capital") and Mr. David Rosen, with respect to the securities held by certain funds and/or accounts (collectively, the "Rubric Vehicles"). Rubric Capital serves as the investment adviser to the Rubric Vehicles. Mr. David Rosen serves as the Managing Member of Rubric Capital Management GP, LLC, the general partner of Rubric Capital. The filing of this statement shall not be deemed an admission that any Reporting Person is the beneficial owner of the securities reported herein for purposes of Section 16 of the Securities Act of 1934, as amended, or otherwise. Each Reporting Person expressly disclaims beneficial ownership of the securities reported herein except to the extent of its or his pecuniary interest therein.

F2: At any time